Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$72.91
$3.07(4.40%)
At close: 4:00 PM EDT
$72.91
$3.07(4.40%)
Day’s Range― - ―
52-Week Range$22.86 - $73.75
Previous CloseN/A
Volume2.48M
Average Volume (3M)4.27M
Market Cap
$11.65B
Enterprise Value$17.21K
Total Cash (Recent Filing)$550.38M
Total Debt (Recent Filing)$2.39B
Price to Earnings (P/E)41.6
Beta1.11
Next Earnings
Oct 29, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.43
Shares Outstanding197,864,240
10 Day Avg. Volume6,175,389
30 Day Avg. Volume4,274,686
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$79.85Price Target Upside9.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)1.7
Revenue Forecast (FY)$15.33B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSizable recent operating and free cash flow with high conversion provide durable funding for operations, debt paydown, tuck-in M&A and technology investment. Reliable FCF increases financial flexibility and lowers dependence on external financing across business cycles.
Scale And Diversified Revenue MixA large, diversified revenue base centered on pharmacy solutions plus growing provider services creates sustainable scale advantages. High script volumes and multi‑setting care delivery support procurement economics, cross‑sell opportunities and resilience to localized demand shifts.
Strong Quality And Operational MetricsIndustry-leading quality, rapid initiation, high medication accuracy and patient satisfaction underpin durable competitive differentiation. These metrics support payer trust, higher referral rates and lower compliance/penalty risk, reinforcing long-term revenue stability and margin improvement.
Bears Say
Thin And Pressured MarginsLow EBITDA margins and multi-year gross margin erosion indicate structural cost pressure in pharmacy and provider operations. Persistent margin compression constrains reinvestment, amplifies sensitivity to reimbursement changes, and reduces the buffer against adverse volume or pricing shocks.
Elevated Leverage RemainsLeverage has improved from peak levels but remains material, limiting strategic flexibility. Ongoing debt servicing and refinancing needs increase vulnerability to cash flow volatility and could constrain acquisition cadence or require higher-cost financing if operating performance weakens.
Regulatory Pricing Headwinds & Early-stage Growth AreasIRA-driven drug pricing changes create structural revenue and margin pressure in home/community pharmacy. Simultaneously, chronic infusion is early and underpenetrated, requiring ongoing investment. Together these factors imply sustained headwinds and continued capital allocation tradeoffs.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $22.86 and its highest was $73.75 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $11.65B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 65 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on Jul 31, 2026. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.396 by $0.054.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.47.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 197,864,240 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.45 in its last earnings report, beating expectations of $0.396. Following the earnings report the stock price went down -18.071%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$79.85 (9.51% Upside)
$79.85 (9.51% Upside)
Blogger Sentiment
Bullish
BTSG Sentiment 60%
Sector Average 61%
Sector Average 61%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.3%
Last 30 Days ▲ 19.4%
Last 30 Days ▲ 19.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
252.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.71%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated broad-based, above-expectation operational and financial execution: strong top-line growth (23% YoY), robust adjusted EBITDA growth (44% YoY), margin expansion, quality and patient satisfaction leadership, balance sheet progress and constructive guidance. Notable headwinds were clearly disclosed—primarily IRA-driven revenue impacts to Home & Community Pharmacy, a one-time tax cash outflow that depressed reported OCF in the quarter, some sequential margin seasonality, and an earlier-stage chronic infusion ramp. On balance the positive growth, margin improvement, quality metrics, cash generation guidance and credit upgrades outweigh the disclosed challenges.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$79.85
▲(9.51% Upside)
Technical Analysis
Ownership Overview
28.15% Insiders
31.44% Mutual Funds
6.37% Other Institutional Investors
13.66% Public Companies and Individual Investors